Kite Pharma has leased a new facility in the Netherlands to engineer cell therapies in Europe. The 117,000 square-foot site in Hoofddorp will be used to manufacture and deliver its cell therapies ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results